Boothbay Fund Management, LLC Synlogic, Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.91 - $14.63 $11,470 - $184,411	-12,605 Reduced 28.99%	30,870 $29,000
Q2 2022 Aug 15, 2022	SELL	$0.89 - $2.47 $2,880 - $7,995	-3,237 Reduced 6.93%	43,475 $50,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $221,869 - $293,220	-97,740 Reduced 67.66%	46,712 $113,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $148,874 - $249,136	-60,765 Reduced 29.61%	144,452 $441,000
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $9,102 - $13,319	3,034 Added 1.5%	205,217 $798,000
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $420,200 - $964,550	191,000 Added 1707.95%	202,183 $724,000
Q4 2020 Feb 12, 2021	BUY	$1.85 - $2.54 $20,688 - $28,404	11,183 New	11,183 $24,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.